Merck Plans Advanced Research Center
Merck celebrated the beginning of construction for the $325 million Advanced Research Center in April of 2024. Located on the company's Darmstadt headquarters campus in Germany, the biopharmaceutical innovation facility will accelerate the development of novel processes and materials for the production of antibodies, recombinant proteins, and viral vectors. The flexible structure will also drive advances in pharmaceutical purification, formulation, and analytical chromatography.